IDENTIFIKASI ADVERSE DRUG REACTION (ADR) OBAT ANTI TUBERKULOSIS PADA PASIEN TB DI RSUD PASAR REBO JAKARTA TIMUR

Dini Permata  Sari; Julita Silitonga; Farisa Luthfiana; Ria  Anggraeni

doi:10.52943/jifarmasi.v9i2.2044

Penulis

Dini Permata Sari Universitas 17 Agustus 1945 Jakarta
Julita Silitonga Universitas 17 Agustus 1945 Jakarta
Farisa Luthfiana Universitas 17 Agustus 1945 Jakarta
Ria Anggraeni Universitas 17 Agustus 1945 Jakarta

DOI:

https://doi.org/10.52943/jifarmasi.v9i2.2044

Kata Kunci:

Tuberculosis, Antituberculosis Drugs, Adverse Drug Reaction

Abstrak

Tuberculosis (TB) remains a major public health problem in Indonesia, ranking second globally in TB burden. Although Anti-Tuberculosis Drugs (ATDs) are effective in curing TB, prolonged treatment and combination regimens may lead to Adverse Drug Reactions (ADRs), potentially affecting patient adherence and treatment outcomes. This study aimed to identify the types of ADRs experienced by TB patients undergoing ATD therapy at Pasar Rebo General Hospital, East Jakarta, and to analyze the relationship between age, gender, and duration of drug use with ADR occurrence. This research employed a descriptive-analytic retrospective design conducted from June to July 2025. A total of 60 adult TB patients receiving first-line ATD therapy (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol) were included. Data were collected using questionnaires and analyzed using univariate and multivariate statistical methods with SPSS. Causality assessment of ADRs was performed using the Naranjo algorithm. The results showed that 88.33% of patients experienced ADRs. The most frequently reported symptoms were nausea (48.33%), rash/itching (28.33%), and joint pain (26.67%). Most ADRs were categorized as “Probable” based on the Naranjo score. Multivariate analysis revealed that gender was significantly associated with ADR occurrence (p = 0.041), while age and duration of drug use were not statistically significant. In conclusion, ADRs are common among TB patients receiving ATD therapy, with gastrointestinal and dermatological symptoms being the most prevalent. Gender appears to be an important predictor of ADR risk. Therefore, close clinical monitoring and gender-sensitive pharmacovigilance strategies are essential to ensure patient safety, improve adherence, and optimize TB treatment outcomes.

Referensi

Ahdiyah, N. N., Andriani, M., & Andriani, L. (2022). Tingkat Kepatuhan Penggunaan Obat Anti Tuberkulosis Pada Pasien TB Paru Dewasa Di Puskesmas Putri Ayu. Lumbung Farmasi: Jurnal Ilmu Kefarmasian, 3(1), 23. https://doi.org/10.31764/lf.v3i1.6817

Dasopang, E. S., Yulianingsih, T., & Lestari, D. A. (2019). Hubungan tingkat kepatuhan minum obat anti tuberkulosis dengan hasil pemeriksaan sputum BTA pada penderita TB paru. Jurnal Kedokteran dan Kesehatan. Jurnal Kedokteran Dan Kesehatan, 15 (2), 152–162.

Hoda dan Hoda. (2020). Tuberculosis therapy: Past, present and future. Journal of Tuberculosis Research. Health Journal, 8 (3), 103–118. https://doi.org/10.4236/jtr.2020.83010

Kemenkes. (2022). Laporan Program Penanggulangan Tuberkulosis Tahun 2021 Kementerian Kesehatan Republik Indonesia Tahun 2022. Kementrian Kesehatan Republik Indonesia, 1.

Kementerian Kesehatan Republik Indonesia. (2021). trategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024. Kementerian Kesehatan RI.

Lestari, N. P. W. A., Dedy, M. A. E., Artawan, I. M., & Buntoro, I. F. (2022). Perbedaan Usia Dan Jenis Kelamin Terhadap Ketuntasan Pengobatan Tb Paru Di Puskesmas Di Kota Kupang. Cendana Medical Journal, 10(1), 24–31. https://doi.org/10.35508/cmj.v10i1.6802

Maharani, & Y. (2023). Prevalence of adverse drug reaction in Indonesia: A systematic review. Journal of Applied Pharmaceutical Science, 13(8), 55–67.

Pangaribuan, Kristina, Perwitasari, Tejayanti, & L. (2020). Faktor-Faktor yang Mempengaruhi Kejadian Tuberkulosis pada Umur 15 Tahun ke Atas di Indonesia. 23 (1), 10–17.

Prasad. Sing, & G. (2019). Adverse drug reactions in tuberculosis and management. In Indian Journal of Tuberculosis. Tuberculosis Association of India, 66 (44), 520–530.

Rahmawati. (2022). Faktor – faktor yang berhubungan dengan kejadian Tuberkulosis Paru pada usia Produktif di Puskesmas Kecamatan Pasar Minggu Tahun 2021. Jurnal Kesehatan Masyarakat, 10 (5), 571–575.

Shan, Cheung,, Zhou, & H. (2023). A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications. In Frontiers in Pharmacology, 14 (3).

Sulistyarini, Susanti, & M. (2021). Profil adverse drug reactions (ADR) pada pasien tuberkulosis paru yang mendapat terapi OAT di RSUP Dr. Sardjito Yogyakarta. Jurnal Farmasi Klinik Indonesia, 10 (1), 36–45. https://doi.org/10.22146/jfki.63742

WHO. (2020). WHO consolidated guidelines on tuberculosis treatment. Geneva: WHO. https://www.who.int/publications/i/item/9789240001503

WHO. (2022). Global tuberculosis report 2022. https://www.who.int/publications/i/item/9789240061729

Yee, Valliquete, pelletier, P. (2003). Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 167 (11, 1472–1477.